Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples